Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | Yes |
Is net profit margin increasing? | Yes | Yes |
Is asset turnover increasing? | No | Yes |
Is equity multiplier increasing? | Yes | Yes |
Competitors Used |
---|
Sanofi |
Ipsen S.A. |
Sartorius Aktiengesellschaft |
Novo Nordisk A/S |
Novartis AG |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
SNW | I7G | SRT | NOV | NOTA | BAYN | |||
Return On Equity | ||||||||
Latest Twelve Months | 7% | 9% | 4% | 81% | 26% | -8% | ||
Fiscal Year - 1 | 7% | 17% | 10% | 88% | 16% | -8% | ||
Fiscal Year - 2 | 11% | 20% | 42% | 72% | 10% | 12% | ||
Fiscal Year - 3 | 9% | 26% | 28% | 71% | 37% | 3% | ||
Fiscal Year - 4 | 20% | 28% | 23% | 70% | 14% | -40% | ||
Fiscal Year - 5 | 5% | -3% | 20% | 71% | 11% | 5% | ||
Average | 10% | 16% | 21% | 75% | 19% | -6% | ||
Median | 8% | 18% | 22% | 72% | 15% | -2% | ||
Benchmarks | Ticker | |||||||
Sanofi | XTRA:SNW | |||||||
Ipsen S.A. | DB:I7G | |||||||
Sartorius Aktiengesellschaft | XTRA:SRT | |||||||
Novo Nordisk A/S | XTRA:NOV | |||||||
Novartis AG | DB:NOTA |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | SNW | I7G | SRT | NOV | NOTA | BAYN | ||
Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
LTM Period | Dec-24 | Dec-24 | Mar-25 | Dec-24 | Dec-24 | Dec-24 | ||
Revenues | ||||||||
Latest Twelve Months | 44,286 | 3,575 | 3,444 | 290,403 | 51,722 | 46,606 | ||
Fiscal Year | 44,286 | 3,575 | 3,381 | 290,403 | 51,722 | 46,606 | ||
Fiscal Year - 1 | 41,109 | 3,306 | 3,396 | 232,261 | 46,660 | 47,637 | ||
Fiscal Year - 2 | 40,304 | 3,156 | 4,175 | 176,954 | 43,461 | 50,739 | ||
Fiscal Year - 3 | 39,175 | 2,749 | 3,449 | 140,800 | 43,974 | 44,081 | ||
Fiscal Year - 4 | 37,369 | 2,686 | 2,336 | 126,946 | 49,898 | 41,400 | ||
Fiscal Year - 5 | 37,631 | 2,693 | 1,827 | 122,021 | 48,677 | 43,545 | ||
Net Income | ||||||||
Latest Twelve Months | 5,496 | 356 | 96 | 100,988 | 11,941 | (2,552) | ||
Fiscal Year | 5,496 | 356 | 84 | 100,988 | 11,941 | (2,552) | ||
Fiscal Year - 1 | 5,062 | 617 | 206 | 83,683 | 8,568 | (2,941) | ||
Fiscal Year - 2 | 7,970 | 593 | 678 | 55,525 | 6,049 | 4,150 | ||
Fiscal Year - 3 | 6,223 | 631 | 319 | 47,757 | 22,908 | 1,000 | ||
Fiscal Year - 4 | 12,294 | 548 | 210 | 42,138 | 8,072 | (15,569) | ||
Fiscal Year - 5 | 2,855 | (55) | 157 | 38,951 | 7,142 | 2,391 | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 126,464 | 6,323 | 10,628 | 314,486 | 99,945 | 116,259 | ||
Latest Fiscal Quarter | 132,798 | 6,439 | 10,112 | 465,795 | 102,246 | 110,850 | ||
Fiscal Year | 132,798 | 6,439 | 10,103 | 465,795 | 102,246 | 110,850 | ||
Fiscal Year - 1 | 126,464 | 6,323 | 9,746 | 314,486 | 99,945 | 116,259 | ||
Fiscal Year - 2 | 126,722 | 5,615 | 6,978 | 241,257 | 117,453 | 124,877 | ||
Fiscal Year - 3 | 120,242 | 4,991 | 5,698 | 194,508 | 131,795 | 120,241 | ||
Fiscal Year - 4 | 114,413 | 4,313 | 4,485 | 144,922 | 127,778 | 116,804 | ||
Fiscal Year - 5 | 112,630 | 4,307 | 2,869 | 125,612 | 118,370 | 126,174 | ||
Fiscal Year - 6 | 111,408 | 3,377 | 2,527 | 110,769 | 145,563 | 126,732 | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 74,040 | 3,825 | 2,672 | 106,561 | 46,667 | 32,927 | ||
Latest Fiscal Quarter | 77,507 | 4,182 | 2,710 | 143,486 | 44,046 | 31,908 | ||
Fiscal Year | 77,507 | 4,182 | 2,765 | 143,486 | 44,046 | 31,908 | ||
Fiscal Year - 1 | 74,040 | 3,825 | 2,068 | 106,561 | 46,667 | 32,927 | ||
Fiscal Year - 2 | 74,784 | 3,344 | 1,990 | 83,486 | 59,342 | 38,773 | ||
Fiscal Year - 3 | 68,681 | 2,735 | 1,260 | 70,746 | 67,655 | 33,020 | ||
Fiscal Year - 4 | 63,106 | 2,131 | 1,031 | 63,325 | 56,598 | 30,523 | ||
Fiscal Year - 5 | 59,056 | 1,751 | 810 | 57,593 | 55,474 | 47,253 | ||
Fiscal Year - 6 | 58,876 | 1,841 | 741 | 51,839 | 78,614 | 45,977 |